Plasma essential amino acid levels in first episode psychosis at baseline and after antipsychotic treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Plasma essential amino acid levels in first episode psychosis at baseline and after antipsychotic treatment ; volume:10 ; number:1 ; day:6 ; month:11 ; year:2024 ; pages:1-7 ; date:12.2024
Schizophrenia ; 10, Heft 1 (6.11.2024), 1-7, 12.2024
- Creator
-
Garip, Beyazit
Khokhar, Jibran Y.
Kayir, Hakan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41537-024-00528-3
- URN
-
urn:nbn:de:101:1-2501242105298.639731123094
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Garip, Beyazit
- Khokhar, Jibran Y.
- Kayir, Hakan
- SpringerLink (Online service)
Other Objects (12)
Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis
Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures
Brain responses to different types of salience in antipsychotic naïve first episode psychosis: An fMRI study
Higher-order functional brain networks and anterior cingulate glutamate + glutamine (Glx) in antipsychotic-naïve first episode psychosis patients
A longitudinal study of hippocampal subfield volumes and hippocampal glutamate levels in antipsychotic-naïve first episode psychosis patients
Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort
Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
Baseline symptom-related white matter tracts predict individualized treatment response to 12-week antipsychotic monotherapies in first-episode schizophrenia
Influence of psychopathology and metabolic parameters on quality of life in patients with first-episode psychosis before and after initial antipsychotic treatment
Identifying persistent negative symptoms in first episode psychosis
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Mitochondrial DNA copy number is associated with psychosis severity and anti-psychotic treatment
Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis
Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures
Brain responses to different types of salience in antipsychotic naïve first episode psychosis: An fMRI study
Higher-order functional brain networks and anterior cingulate glutamate + glutamine (Glx) in antipsychotic-naïve first episode psychosis patients
A longitudinal study of hippocampal subfield volumes and hippocampal glutamate levels in antipsychotic-naïve first episode psychosis patients
Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort
Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
Baseline symptom-related white matter tracts predict individualized treatment response to 12-week antipsychotic monotherapies in first-episode schizophrenia
Influence of psychopathology and metabolic parameters on quality of life in patients with first-episode psychosis before and after initial antipsychotic treatment
Identifying persistent negative symptoms in first episode psychosis
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia
Mitochondrial DNA copy number is associated with psychosis severity and anti-psychotic treatment
Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis
Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures
Brain responses to different types of salience in antipsychotic naïve first episode psychosis: An fMRI study
Higher-order functional brain networks and anterior cingulate glutamate + glutamine (Glx) in antipsychotic-naïve first episode psychosis patients
A longitudinal study of hippocampal subfield volumes and hippocampal glutamate levels in antipsychotic-naïve first episode psychosis patients
Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort
Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
Baseline symptom-related white matter tracts predict individualized treatment response to 12-week antipsychotic monotherapies in first-episode schizophrenia
Influence of psychopathology and metabolic parameters on quality of life in patients with first-episode psychosis before and after initial antipsychotic treatment
Identifying persistent negative symptoms in first episode psychosis
Choroid plexus volume enlargement in first-episode antipsychotic-naïve schizophrenia